Ninlaro OverviewIxazomib (trade name Ninlaro) is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is taken by mouth in form of capsules. Common side effects include diarrhoea, constipation and low platelet count. Like the older bortezomib (which can only be given by injection), it acts as a proteasome inhibitor, has orphan drug status in the US and Europe, and is a boronic acid derivative. The drug was developed by Takeda....
Read more Ninlaro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ixazomib
Recent Ninlaro Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 2.3mg, 3mg, 4mg
NDC Database Records for Ninlaro: (3 results)Sorted by National Drug Code
- 63020-078 Ninlaro 2.3 mg Oral Capsule by Millennium Pharmaceuticals, Inc.
- 63020-079 Ninlaro 3 mg Oral Capsule by Millennium Pharmaceuticals, Inc.
- 63020-080 Ninlaro 4 mg Oral Capsule by Millennium Pharmaceuticals, Inc.